Nishino, M., Gargano, M., Suda, M., Ramaiya, N. H., & Hodi, F. S. (2014). Optimizing immune-related tumor response assessment: Does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? BioMed Central.

Nishino, Mizuki, Maria Gargano, Margaret Suda, Nikhil H. Ramaiya, et F Stephen Hodi. Optimizing Immune-related Tumor Response Assessment: Does Reducing the Number of Lesions Impact Response Assessment in Melanoma Patients Treated With Ipilimumab? BioMed Central, 2014.

Nishino, Mizuki, et al. Optimizing Immune-related Tumor Response Assessment: Does Reducing the Number of Lesions Impact Response Assessment in Melanoma Patients Treated With Ipilimumab? BioMed Central, 2014.